Machine Learning-based Exceptional Response Prediction of Nivolumab Monotherapy with Circulating MicroRNAs in Non-Small Cell Lung Cancer

https://www.lungcancerjournal.info/article/S0169-5002(22)00618-3/fulltext#.Yx8Exv19YqE.twitter